News | November 11, 2022
Ayu Health receives US $27 million additional funding
The company is making its entry into the Hyderabad market through its unique asset-light business model
The company is making its entry into the Hyderabad market through its unique asset-light business model
Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems
Saroglitazar Mg is an investigational compound in the USA/EU, undergoing Phase 2b/3 clinical trials in patients with Primary Biliary Cholangitis and Phase 2b in patients with Non- alcoholic Steatohepatitis
The laboratory is equipped to perform high-volume diagnostic testing services
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Results reinforce commitment to next-generation oral SERD development programme
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
Subscribe To Our Newsletter & Stay Updated
